Selected research
Industry Research
Genomic Data Analysis Service Industry Research Report 2026
Market perspective
The global Genomic Data Analysis Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Genomic Data Analysis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Genomic Data Analysis Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Genomic Data Analysis Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Genomic Data Analysis Service include Illumina, QIAGEN Digital Insights, BGI Genomics, Eurofins Genomics, Charles River Laboratories, CellCarta, CD Genomics, Fios Genomics and Basepair, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Genomic Data Analysis Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Genomic Data Analysis Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Genomic Data Analysis Service Market by Company
Illumina
QIAGEN Digital Insights
BGI Genomics
Eurofins Genomics
Charles River Laboratories
CellCarta
CD Genomics
Fios Genomics
Basepair
Golden Helix
DNAnexus
Seven Bridges(Velsera)
SOPHiA GENETICS
Fabric Genomics
Congenica
Novogene
GENEWIZ
Macrogen
AWS HealthOmics
Genomic Data Analysis Service Segment by Type
Cloud-Based SaaS Services
On-Premises Deployment Services
Genomic Data Analysis Service Segment by Application
Healthcare
Biomedicine
Scientific Research and Education
Agricultural Breeding
Others
Genomic Data Analysis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genomic Data Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genomic Data Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genomic Data Analysis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Genomic Data Analysis Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-Based SaaS Services
- On-Premises Deployment Services
Applications
- Healthcare
- Biomedicine
- Scientific Research and Education
- Agricultural Breeding
- Others
Companies covered
- Illumina
- QIAGEN Digital Insights
- BGI Genomics
- Eurofins Genomics
- Charles River Laboratories
- CellCarta
- CD Genomics
- Fios Genomics
- Basepair
- Golden Helix
- DNAnexus
- Seven Bridges(Velsera)
- SOPHiA GENETICS
- Fabric Genomics
- Congenica
- Novogene
- GENEWIZ
- Macrogen
- AWS HealthOmics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Genomic Data Analysis Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud-Based SaaS Services
- 2.2.3 On-Premises Deployment Services
- 2.3 Genomic Data Analysis Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Healthcare
- 2.3.3 Biomedicine
- 2.3.4 Scientific Research and Education
- 2.3.5 Agricultural Breeding
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Genomic Data Analysis Service Breakdown Data by Type
- 3.1 Global Genomic Data Analysis Service Historic Market Size by Type (2021-2026)
- 3.2 Global Genomic Data Analysis Service Forecasted Market Size by Type (2027-2032)
4 Genomic Data Analysis Service Breakdown Data by Application
- 4.1 Global Genomic Data Analysis Service Historic Market Size by Application (2021-2026)
- 4.2 Global Genomic Data Analysis Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Genomic Data Analysis Service Market Perspective (2021-2032)
- 5.2 Global Genomic Data Analysis Service Growth Trends by Region
- 5.2.1 Global Genomic Data Analysis Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Genomic Data Analysis Service Historic Market Size by Region (2021-2026)
- 5.2.3 Genomic Data Analysis Service Forecasted Market Size by Region (2027-2032)
- 5.3 Genomic Data Analysis Service Market Dynamics
- 5.3.1 Genomic Data Analysis Service Industry Trends
- 5.3.2 Genomic Data Analysis Service Market Drivers
- 5.3.3 Genomic Data Analysis Service Market Challenges
- 5.3.4 Genomic Data Analysis Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Genomic Data Analysis Service Players by Revenue
- 6.1.1 Global Top Genomic Data Analysis Service Players by Revenue (2021-2026)
- 6.1.2 Global Genomic Data Analysis Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Genomic Data Analysis Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Genomic Data Analysis Service Head Office and Area Served
- 6.4 Global Genomic Data Analysis Service Players, Product Type & Application
- 6.5 Global Genomic Data Analysis Service Manufacturers Established Date
- 6.6 Global Genomic Data Analysis Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Genomic Data Analysis Service Market Size (2021-2032)
- 7.2 North America Genomic Data Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Genomic Data Analysis Service Market Size by Country (2021-2026)
- 7.4 North America Genomic Data Analysis Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Genomic Data Analysis Service Market Size (2021-2032)
- 8.2 Europe Genomic Data Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Genomic Data Analysis Service Market Size by Country (2021-2026)
- 8.4 Europe Genomic Data Analysis Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Genomic Data Analysis Service Market Size (2021-2032)
- 9.2 Asia-Pacific Genomic Data Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Genomic Data Analysis Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Genomic Data Analysis Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Genomic Data Analysis Service Market Size (2021-2032)
- 10.2 South America Genomic Data Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Genomic Data Analysis Service Market Size by Country (2021-2026)
- 10.4 South America Genomic Data Analysis Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Genomic Data Analysis Service Market Size (2021-2032)
- 11.2 Middle East & Africa Genomic Data Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Genomic Data Analysis Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Genomic Data Analysis Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Illumina
- 12.1.1 Illumina Company Information
- 12.1.2 Illumina Business Overview
- 12.1.3 Illumina Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.1.4 Illumina Genomic Data Analysis Service Product Portfolio
- 12.1.5 Illumina Recent Developments
- 12.2 QIAGEN Digital Insights
- 12.2.1 QIAGEN Digital Insights Company Information
- 12.2.2 QIAGEN Digital Insights Business Overview
- 12.2.3 QIAGEN Digital Insights Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.2.4 QIAGEN Digital Insights Genomic Data Analysis Service Product Portfolio
- 12.2.5 QIAGEN Digital Insights Recent Developments
- 12.3 BGI Genomics
- 12.3.1 BGI Genomics Company Information
- 12.3.2 BGI Genomics Business Overview
- 12.3.3 BGI Genomics Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.3.4 BGI Genomics Genomic Data Analysis Service Product Portfolio
- 12.3.5 BGI Genomics Recent Developments
- 12.4 Eurofins Genomics
- 12.4.1 Eurofins Genomics Company Information
- 12.4.2 Eurofins Genomics Business Overview
- 12.4.3 Eurofins Genomics Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.4.4 Eurofins Genomics Genomic Data Analysis Service Product Portfolio
- 12.4.5 Eurofins Genomics Recent Developments
- 12.5 Charles River Laboratories
- 12.5.1 Charles River Laboratories Company Information
- 12.5.2 Charles River Laboratories Business Overview
- 12.5.3 Charles River Laboratories Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.5.4 Charles River Laboratories Genomic Data Analysis Service Product Portfolio
- 12.5.5 Charles River Laboratories Recent Developments
- 12.6 CellCarta
- 12.6.1 CellCarta Company Information
- 12.6.2 CellCarta Business Overview
- 12.6.3 CellCarta Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.6.4 CellCarta Genomic Data Analysis Service Product Portfolio
- 12.6.5 CellCarta Recent Developments
- 12.7 CD Genomics
- 12.7.1 CD Genomics Company Information
- 12.7.2 CD Genomics Business Overview
- 12.7.3 CD Genomics Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.7.4 CD Genomics Genomic Data Analysis Service Product Portfolio
- 12.7.5 CD Genomics Recent Developments
- 12.8 Fios Genomics
- 12.8.1 Fios Genomics Company Information
- 12.8.2 Fios Genomics Business Overview
- 12.8.3 Fios Genomics Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.8.4 Fios Genomics Genomic Data Analysis Service Product Portfolio
- 12.8.5 Fios Genomics Recent Developments
- 12.9 Basepair
- 12.9.1 Basepair Company Information
- 12.9.2 Basepair Business Overview
- 12.9.3 Basepair Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.9.4 Basepair Genomic Data Analysis Service Product Portfolio
- 12.9.5 Basepair Recent Developments
- 12.10 Golden Helix
- 12.10.1 Golden Helix Company Information
- 12.10.2 Golden Helix Business Overview
- 12.10.3 Golden Helix Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.10.4 Golden Helix Genomic Data Analysis Service Product Portfolio
- 12.10.5 Golden Helix Recent Developments
- 12.11 DNAnexus
- 12.11.1 DNAnexus Company Information
- 12.11.2 DNAnexus Business Overview
- 12.11.3 DNAnexus Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.11.4 DNAnexus Genomic Data Analysis Service Product Portfolio
- 12.11.5 DNAnexus Recent Developments
- 12.12 Seven Bridges(Velsera)
- 12.12.1 Seven Bridges(Velsera) Company Information
- 12.12.2 Seven Bridges(Velsera) Business Overview
- 12.12.3 Seven Bridges(Velsera) Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.12.4 Seven Bridges(Velsera) Genomic Data Analysis Service Product Portfolio
- 12.12.5 Seven Bridges(Velsera) Recent Developments
- 12.13 SOPHiA GENETICS
- 12.13.1 SOPHiA GENETICS Company Information
- 12.13.2 SOPHiA GENETICS Business Overview
- 12.13.3 SOPHiA GENETICS Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.13.4 SOPHiA GENETICS Genomic Data Analysis Service Product Portfolio
- 12.13.5 SOPHiA GENETICS Recent Developments
- 12.14 Fabric Genomics
- 12.14.1 Fabric Genomics Company Information
- 12.14.2 Fabric Genomics Business Overview
- 12.14.3 Fabric Genomics Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.14.4 Fabric Genomics Genomic Data Analysis Service Product Portfolio
- 12.14.5 Fabric Genomics Recent Developments
- 12.15 Congenica
- 12.15.1 Congenica Company Information
- 12.15.2 Congenica Business Overview
- 12.15.3 Congenica Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.15.4 Congenica Genomic Data Analysis Service Product Portfolio
- 12.15.5 Congenica Recent Developments
- 12.16 Novogene
- 12.16.1 Novogene Company Information
- 12.16.2 Novogene Business Overview
- 12.16.3 Novogene Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.16.4 Novogene Genomic Data Analysis Service Product Portfolio
- 12.16.5 Novogene Recent Developments
- 12.17 GENEWIZ
- 12.17.1 GENEWIZ Company Information
- 12.17.2 GENEWIZ Business Overview
- 12.17.3 GENEWIZ Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.17.4 GENEWIZ Genomic Data Analysis Service Product Portfolio
- 12.17.5 GENEWIZ Recent Developments
- 12.18 Macrogen
- 12.18.1 Macrogen Company Information
- 12.18.2 Macrogen Business Overview
- 12.18.3 Macrogen Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.18.4 Macrogen Genomic Data Analysis Service Product Portfolio
- 12.18.5 Macrogen Recent Developments
- 12.19 AWS HealthOmics
- 12.19.1 AWS HealthOmics Company Information
- 12.19.2 AWS HealthOmics Business Overview
- 12.19.3 AWS HealthOmics Revenue in Genomic Data Analysis Service Business (2021-2026)
- 12.19.4 AWS HealthOmics Genomic Data Analysis Service Product Portfolio
- 12.19.5 AWS HealthOmics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst